Navigation Links
Women's Peripheral Artery Disease Tied to Secondhand Smoke
Date:9/22/2008

They face 69% increased risk for heart disease, 56% risk of ischemic stroke, study finds

MONDAY, Sept. 22 (HealthDay News) -- Women exposed to secondhand smoke at home or in the workplace had a 67 percent increased risk of peripheral artery disease (PAD) compared to women who weren't exposed, a new study says.

"This is the first study to show the adverse effects of secondhand smoke on peripheral artery disease in women," lead author Yao He, a professor of epidemiology at the Chinese PLA General Hospital in Beijing, said in an American Heart Association news release.

The researchers, who examined 1,209 Chinese women 60 years and older who'd never smoked, also found that exposure to secondhand smoke increased the risk of coronary heart disease by 69 percent and the risk of ischemic stroke by 56 percent. Ischemic stroke occurs when a blockage cuts off blood supply to the brain.

For the study, secondhand smoke exposure was defined as exposure to tobacco smoke for at least 15 minutes daily for more than one day every week for at least two years during the past 10 years.

Among the women in the study, 477 (39.5 percent) were exposed to secondhand smoke -- 414 (86.8 percent) at home and 63 (13.2 percent) in the workplace. Overall, there were 271 cases of PAD, 431 cases of coronary disease, and 172 cases of stroke, 109 of which were ischemic stroke.

The findings were published Sept. 22 in the journal Circulation.

"This study broadens the finding about the detrimental health effects of passive smoking on heart disease and stroke," senior author Frank Hu, a professor of nutrition and epidemiology at the Harvard School of Public Health, said in the news release.

Even though this study focused on women, it's likely that secondhand smoke has the same harmful effects on men, Hu said.

More information

The U.S. Centers for Disease Control and Prevention has m
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Womenshealthchannel Enhancements Support Pregnant Teens
2. First-Ever National Ranking of Hot Spots for Peripheral Artery Disease (P.A.D.) Identifies Cities With Higher Risk of Heart Attack and Stroke
3. Vermillion Announces Publication of Data Supporting Its Peripheral Artery Disease Diagnostic Test Program
4. Summit Doppler Announces the Seated ABI for the Diagnosis of Peripheral Arterial Disease
5. Insulin Resistance Tied to Peripheral Artery Disease
6. Vermillion to Host Live Roundtable Discussion With Lead Investigator of its Peripheral Artery Disease Diagnostic Test Program
7. Low Vitamin D Levels Associated With an Increased Risk of Peripheral Arterial Disease
8. Genetic mutation found in peripheral artery disease
9. GPS Devices Measure Severity of Peripheral Artery Disease
10. Terumo Launches the New AZUR(TM) Peripheral HydroCoil(R) Embolization System with Expanding Hydrogel Technology
11. Peripheral Arterial Disease Costlier to Treat Than Heart Trouble

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...type device to be coupled with Stem Cell Therapy. ...ovember 24, 2009 -- Entest Biomedical, Inc. (OTC...ons with a manufacturer of lasers regarding the de...l be owned by Entest and used in conjunction with ...ped by Entest. These therapies are aimed at increa...
(Date:11/24/2009)...l Tips to Get a Leg Up From the American Podiatric...thesda, Md. (Vocus) November 24, 2009 -- The avera...dash;but that number dramatically increases during...s alike continue making their holiday travel plans...ar the brunt of aches and pains while on the road....
(Date:11/24/2009)...wire/--MinuteClinic,thepioneerandlargestproviderof...tsfirstretailhealthcarecenterinWashington,D.C.insi...pensevendaysaweekandwillservepatientsinNortheastne...anPark,AtlasDistrict,IvyCityandtheGallaudetUnivers...ore-basedclinic,weareexpandingaccesstohigh-quality...
(Date:11/24/2009)...wswire-FirstCall/--AflacIncorporated(NYSE: AFL )an...dtheexchangeoftwoofitsinvestmentsecuritiesownedbyA...November3,2009,andtheexchangesareexpectedtosettleo...flacwillhaveexchangeditsinvestmentinLloydsTSBBankp...arvalueof$222millionatSeptember30,2009)intoyen-den...
(Date:11/24/2009)...redators, but few fear cyberbullying, survey finds...- More than four in five parents say their childre...at the same time almost two-thirds are worried abo...The findings, released online Nov. 19 by the C.S. ...,s Health, show that parents have a variety of con...
Breaking Medicine News(10 mins):Health News:Entest Biomedical Enters into Discussions with Laser Manufacturer to Develop Proprietary Photoceutical Device for COPD Treatment 2Health News:Keep Holiday Travel Foot-Friendly 2Health News:Keep Holiday Travel Foot-Friendly 3Health News:MinuteClinic Opens First Retail Clinic in Washington, D.C. at CVS/pharmacy Store in Northeast 2Health News:MinuteClinic Opens First Retail Clinic in Washington, D.C. at CVS/pharmacy Store in Northeast 3Health News:Aflac To Exchange Two Lloyds Banking Group Securities, Enhance Risk-Based Capital Ratio 2Health News:Aflac To Exchange Two Lloyds Banking Group Securities, Enhance Risk-Based Capital Ratio 3Health News:Aflac To Exchange Two Lloyds Banking Group Securities, Enhance Risk-Based Capital Ratio 4Health News:Parents Worry About Their Kids' Safety on the Internet 2
... gets tough, the tough get fitter, and healthier. ...is still going strong despite these challenging ec...owth strategy not only for this year but for many ...ak. , , Known for its innovative results-oriente...
...ry in Miami today convicted two physicians and two...ion Medicare fraud scheme, Acting Assistant Attorn... and U.S. Attorney R. Alexander Acosta of the Sout...65; Eda Marietta Milanes, 43; and Jorge Luis Pache...
...amp; Sullivan will present the 2009 Excellence in... Market to Epinex for developing the G1A(TM) Rapi...livan is an internationally renowned market resear...llence in Medical Technologies & Life Sciences...
...ng event was announced today by the American Red C...ter Los Angeles Red Cross is hosting a lunch recep...ency Operations Center (EOC), which is ready to be...ge will run throughout the event. , , Who: More...
...ty revenue triples and GCC sales start , , QUEBEC...e Inc. (TSX: CUR), a life sciences company commerc...livering lab services, announced a net loss of $3,...eflect budgeted sales and marketing initiatives to...
...argest water efficiency conference Oct. 7-9 in Las...t of its ongoing commitment to encourage efficient... Association (AWWA), the authoritative resource o...ed last year by the Southern Nevada Water Authorit...
Other Medicine News:Health News:Equinox Fitness Clubs Grows With The Flow 2Health News:Jury Convicts Two Doctors and Two Medical Assistants in $5.3 Million Medicare Fraud Scam 2Health News:Jury Convicts Two Doctors and Two Medical Assistants in $5.3 Million Medicare Fraud Scam 3Health News:Jury Convicts Two Doctors and Two Medical Assistants in $5.3 Million Medicare Fraud Scam 4Health News:Frost and Sullivan Picks Epinex for Diabetes Research Award 2Health News:State-of-the-Art Preparedness: L.A. Red Cross Opens Advanced Emergency Operations Center 2Health News:DiagnoCure announces first quarter 2009 results 2Health News:DiagnoCure announces first quarter 2009 results 3Health News:DiagnoCure announces first quarter 2009 results 4Health News:DiagnoCure announces first quarter 2009 results 5Health News:DiagnoCure announces first quarter 2009 results 6Health News:AWWA partners with WaterSmart Innovations conference 2
(Date:11/24/2009)...,Nov.24/PRNewswire-Asia/--HuifengBio-Pharmaceutica...eveloperandproducer,ofplantextractsandpharmaceutic...landfoodproductioninXi,an,China,todayreportedthati...revenues. , RevenuesforthequarterendedSept.30...om$3,534,623forthesamequarterin2008.Netincome,amou...
(Date:11/24/2009)...OOD,Calif.,Nov.24/PRNewswire-FirstCall/--IPCTheHos...alhospitalistphysiciangrouppracticecompany,announc...t,wasnamedby ACPHospitalist asoneofthe2009TopTenHo...2009issueofthemagazine. ,, Dr.Vaidyanhasbeenapr...vesasdirectorofhospitalmedicineatSt.Mary,sHealthCe...
(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/--ZimmerHoldings,Inc....atinginthe21stAnnualPiperJaffrayHealthCareConferen...ternTime. ,, Alivewebcastofthepresentationcanbe...://investor.zimmer.com .Thewebcastwillbearchivedfo...any ,, Foundedin1927andheadquarteredinWarsaw,I...
Breaking Medicine Technology:Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 2Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 3IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 2Watson Pharmaceuticals Resumes Shipment of INFeD 28R 29 28Iron Dextran Injection USP 29 51309 1Watson Pharmaceuticals Resumes Shipment of INFeD 28R 29 28Iron Dextran Injection USP 29 51309 2Watson Pharmaceuticals Resumes Shipment of INFeD 28R 29 28Iron Dextran Injection USP 29 51309 3Connectyx Looks to Establish Market Leadership with MedSync and MedFlash Product Line As Stated During Nationwide Teleconference 51307 1Connectyx Looks to Establish Market Leadership with MedSync and MedFlash Product Line As Stated During Nationwide Teleconference 51307 2Connectyx Looks to Establish Market Leadership with MedSync and MedFlash Product Line As Stated During Nationwide Teleconference 51307 3Bioniche Life Sciences Inc and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin 28TM 29 4712 1Bioniche Life Sciences Inc and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin 28TM 29 4712 2Bioniche Life Sciences Inc and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin 28TM 29 4712 3Bioniche Life Sciences Inc and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin 28TM 29 4712 4Bioniche Life Sciences Inc and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin 28TM 29 4712 5Bioniche Life Sciences Inc and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin 28TM 29 4712 6
...lood pressure reductions of 30.8 mm Hg,systolic bl...pressure (DBP),at five weeks and 21.1/19.3 mm Hg (... of patients with severe hypertension, AVAL...4.6 mm Hg (SBP/DBP), at 8 weeks, and 22.1/11.6 mm...ectively for irbesartan and HCTZ alone, in a study...
...Proprietary siRNA Molecule in Acute .... 19 Quark Pharmaceuticals, Inc., a,development-s... and,developing novel RNA interference-based thera...temic dosing in humans of its proprietary product,... developed by Quark for,the treatment of Acute Ren...
Other Medicine Technology:Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood 2Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood 3Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood 4Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood 5Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood 6Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood 7Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans 2Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans 3Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans 4
Schepens Depressor 8.0mm Wide Tip Thimble Size 12
Yavitz Flap Cover
Chayett Drainage Ring
Weck-Cel Points
Medicine Products: